Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
More NewsRead More
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
September 12, 2024
Via The Motley Fool
Via Benzinga
Evaluating Novo Nordisk: Insights From 8 Financial Analysts
September 09, 2024
Via Benzinga
What the Options Market Tells Us About Novo Nordisk
September 06, 2024
Via Benzinga
Novo Nordisk Unusual Options Activity
September 05, 2024
Via Benzinga
Why Roche Holdings Stock Withered on Wednesday
September 11, 2024
Via The Motley Fool
Why Viking Therapeutics Stock Rocked the Market Today
September 11, 2024
Via The Motley Fool
Is Merck Stock Undervalued After Its Colossal Earnings Growth?
September 07, 2024
Via MarketBeat
Goldman Sachs Shifts Stance On Novartis, Cites Lack Of Near-Term Catalysts
September 05, 2024
Via Benzinga
Via Benzinga
Via Benzinga
Ascendis Pharma Faces Challenges With Skytrofa And Yorvipath Pricing: Analysts Weigh In
September 04, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|